Myopia at Age 8
What to Expect and What to Do

Short answer: Age 8 is when MiSight® 1 day contact lenses become FDA-approved for myopia management — a significant clinical milestone. Children with myopia at 8 are in the highest-risk age group and benefit substantially from early treatment. Stellest® spectacle lenses are an equally effective option without the contact lens fitting.

Current growth phase at age 8: Fast growth phase — axial length growing at 0.20–0.35mm/year on average

Clinical picture: what this age means for myopia

The Chamberlain et al. 2019 MiSight RCT enrolled children from age 8 and demonstrated 55% reduction in axial elongation over 3 years compared to single-vision lenses. Bao et al. 2022 (Stellest) similarly enrolled from age 8 and showed 67% reduction at 2 years. Both trials support the value of starting management at this age — and the IMI 2025 consensus does not recommend waiting.

What parents should do now

Treatment options at age 8

MiSight® 1 day (FDA-approved from age 8), Stellest® (school age), low-dose atropine (any age under supervision), orthokeratology (from ~age 7–8). Clinical profile and family preference guide choice.

See your child's projected prescription at age 18

Enter current age, axial length, and a prior measurement. Get projected adult prescription with and without treatment — in under 60 seconds.

Project myopia progression →
Free · No login · Under 30 seconds

How age at onset predicts lifetime risk

Age myopia startsYears of fast growth remainingHigh myopia risk (without treatment)
Age 6~12 yearsVery high (est. 60–80%)
Age 7~11 yearsVery high (est. 55–75%)
Age 8~10 yearsHigh (est. 45–65%)
Age 9~9 yearsHigh (est. 35–55%)
Age 10~8 yearsModerate–High (est. 25–45%)
Age 12~6 yearsModerate (est. 15–30%)
Age 14~4 yearsLower (est. 10–20%)
Age 16~2 yearsLow (est. 5–12%)

High myopia defined as ≥−6.00D. Risk estimates based on Tideman 2018 longitudinal data; individual outcomes vary substantially. Your row is highlighted.

Sources: Tideman JWL et al. Acta Ophthalmologica. 2018;96(3):301–309 (normative AL curves, age at onset) · Sanz Diez P et al. Ophthalmic Physiol Opt. 2019 (meta-analysis, onset age) · IMI 2025 Digest — Tahhan N et al. · Donovan L et al. Ophthalmic Physiol Opt. 2012;32(3):240–247 (stabilisation data) · Chamberlain P et al. Optom Vis Sci. 2019 (MiSight RCT, age 8+) · Bao J et al. JAMA Ophthalmol. 2022 (Stellest RCT)

This page is for educational purposes and does not constitute medical advice. Diopter-to-axial-length conversions are approximations (±2–3D individual variation). MyopiaTracker is a decision-support tool — not a diagnostic device. Consult a qualified optometrist or ophthalmologist for personalised advice.